Following the path: Increasing trends of HIV-1 drug resistance in China
Author:
Funder
Swedish Research Council
Publisher
Elsevier BV
Subject
General Medicine
Reference10 articles.
1. UNAIDS. 90–90–90: An ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: UNAIDS; 2014. http://www.unaids.org/en/resources/documents/2014/90-90-90. Accessed December 14, 2019.
2. WHO. HIV drug resistance report 2019. https://www.who.int/hiv/pub/drugresistance/hivdr-report-2019/en/. Accessed December 14, 2019.
3. HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the Treat Asia Studies to evaluate resistance-monitoring study;Sungkanuparph;Clin Infect Dis,2011
4. Transmitted HIV-1 drug resistance in a treatment-naive cohort of recently infected individuals from Chennai, India;Nesakumar;AIDS Res Hum Retroviruses,2019
5. HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis;Gupta;Lancet Infect Dis,2018
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genetic Diversity and Characteristics of Drug Resistance Among Treatment-Naive People Living with HIV in Xi’an, China;Drug Design, Development and Therapy;2023-05
2. Prevalence of transmitted drug resistance among ART-naïve HIV-infected individuals, Beijing, 2015–2018;Journal of Global Antimicrobial Resistance;2022-03
3. Genetic Diversity, Complicated Recombination, and Deteriorating Drug Resistance Among HIV-1-Infected Individuals in Wuhan, China;AIDS Research and Human Retroviruses;2021-03-01
4. Optimizing Discrete Simulations of the Spread of HIV-1 to Handle Billions of Cells on a Workstation;Proceedings of the 2020 ACM SIGSIM Conference on Principles of Advanced Discrete Simulation;2020-06-06
5. 2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication;Molecules;2020-03-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3